A new coronavirus variant is sweeping through Europe and the United States as officials advise ramping up monitoring of its ...

The BNT162b2 XBB1.5-adapted vaccine demonstrated lower effectiveness against JN.1 vs XBB sublineages, according to study findings.

The vaccines were changed to target a strain of the virus that causes COVID-19 called XBB.1.5. In September and October 2023 ... even after more than 650 million doses have been given in the United ...

XEC is a recombinant variant, meaning it’s a hybrid of two previously existing variants. Genomic data suggests it’s making up ...

Mexico's top economic official is suggesting that his country will actively take the U.S. side in looming trade battles with ...

The federal government’s decision to not provide Novavax’s COVID-19 vaccine this respiratory virus season raises health ...

The global BB cream market is poised for significant growth, with an estimated valuation of USD 4,078.1 million in 2023, projected to reach USD 9,135.8 million by 2033. This represents a robust ...

Investing in Real Assets with BREA ETF Brompton Sustainable Real Assets Dividend ETF (Ticker: BREA) is an actively managed, ...

NEW YORK — Alex Cobb and Tanner Bibee will start Games 1 and 2 for the Cleveland Guardians against the New York Yankees in ...

Pfizer Inc. (NYSE: PFE) will present data across its infectious disease portfolio at the upcoming IDWeek 2024 congress, held ...

Presentations highlight momentum of Pfizer's portfolio of infectious disease prevention and treatment options NEW YORK, October 8, 2024 - Pfizer Inc ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new findings from its antiviral research ...